| |
| |
|
| Insider
Information: |
Smith Hunter C |
| Relationship: |
Chief Financial Officer |
| City: |
Darien |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
97,939 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,494,464 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,939 |
|
|
| Total
Value |
$3,494,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genesee & Wyoming Inc |
GWR |
Director |
2019-12-30 |
0 |
2015-03-31 |
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
Chief Financial Officer |
2024-03-19 |
97,939 |
2018-09-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-12-30 |
4 |
D |
$112.00 |
$1,324,288 |
D/D |
(11,824) |
0 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-09-30 |
4 |
A |
$110.67 |
$18,371 |
D/D |
166 |
11,824 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-06-30 |
4 |
A |
$98.57 |
$30,261 |
D/D |
307 |
11,658 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2015-03-31 |
4 |
A |
$97.19 |
$680 |
D/D |
7 |
7 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2018-09-30 |
4 |
A |
$91.61 |
$22,811 |
D/D |
249 |
9,573 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-03-31 |
4 |
A |
$86.88 |
$25,282 |
D/D |
291 |
10,190 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2019-05-22 |
4 |
A |
$86.07 |
$99,927 |
D/D |
1,161 |
11,351 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2018-06-30 |
4 |
A |
$80.48 |
$18,430 |
D/D |
229 |
9,324 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2017-12-31 |
4 |
A |
$78.72 |
$28,418 |
D/D |
361 |
7,496 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2015-06-30 |
4 |
A |
$76.62 |
$16,550 |
D/D |
216 |
1,226 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2018-12-31 |
4 |
A |
$73.80 |
$24,059 |
D/D |
326 |
9,899 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2017-09-30 |
4 |
A |
$73.53 |
$18,383 |
D/D |
250 |
7,135 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2018-03-31 |
4 |
A |
$70.14 |
$20,902 |
D/D |
298 |
7,794 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2016-12-31 |
4 |
A |
$69.59 |
$24,635 |
D/D |
354 |
4,955 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2016-09-30 |
4 |
A |
$68.10 |
$20,907 |
D/D |
307 |
4,601 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2017-03-31 |
4 |
A |
$68.10 |
$18,387 |
D/D |
270 |
5,225 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$67.83 |
$18,382 |
D/D |
271 |
6,885 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2016-03-31 |
4 |
A |
$63.30 |
$23,421 |
D/D |
370 |
2,343 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2015-09-30 |
4 |
A |
$57.51 |
$23,407 |
D/D |
407 |
1,633 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2016-06-30 |
4 |
A |
$57.23 |
$20,889 |
D/D |
365 |
4,294 |
0 |
- |
|
| GWR |
Genesee & Wyoming Inc |
Director |
– • – |
2015-12-31 |
4 |
A |
$54.08 |
$18,387 |
D/D |
340 |
1,973 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2024-02-12 |
4 |
AS |
$51.38 |
$62,118 |
D/D |
(1,209) |
80,413 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2024-02-13 |
4 |
AS |
$49.82 |
$35,322 |
D/D |
(709) |
79,704 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
AS |
$45.06 |
$72,817 |
D/D |
(1,616) |
75,215 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-12-06 |
4 |
AS |
$40.00 |
$800,000 |
D/D |
(20,000) |
61,406 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
